On the stock market since 2011, it operates in the world of health and science. It has 129 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 18% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $62.3M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades 20% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 28% a year on average.
There is $69.1M in the vault; even if every debt were paid off, $62.3M would remain.
The company’s market value is 66 times its annual profit. Even a small disappointment could hit the price hard.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
On our five-subject report card, BRSYF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: BRSYF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.